Literature DB >> 14582169

The future of kidney preservation.

F O Belzer1, J H Southard.   

Abstract

Both methods of hypothermic preservation of kidneys currently used clinically have been and continue to be useful procedures for the transplant surgeon. Each method has its limitations, benefits, and potential detriments. Which method is best is not a fully resolved question and the method of choice appears to be dependent upon, to a large extent, personal preference and circumstances. There is, however, a vital need for long-term kidney preservation. Obtaining this goal will most likely require carefully controlled experimental studies linking the biochemical and physiological aspects of organ metabolism at hypothermia to the design of perfusates, perfusion machine technology, and drug therapy. Improvements in perfusion preservation methodology based on sound basic data rather than by serendipity appears to offer the best opportunity for obtaining good quality long-term preservation.

Entities:  

Mesh:

Year:  1980        PMID: 14582169     DOI: 10.1097/00007890-198009000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Optimal flow and pressure management in machine perfusion systems for organ preservation.

Authors:  Ivo C J H Post; Marcel C Dirkes; Michal Heger; Rick Bezemer; Johan van 't Leven; Thomas M van Gulik
Journal:  Ann Biomed Eng       Date:  2012-06-06       Impact factor: 3.934

Review 2.  Ex-vivo Kidney Machine Perfusion: Therapeutic Potential.

Authors:  Ruta Zulpaite; Povilas Miknevicius; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Front Med (Lausanne)       Date:  2021-12-24

3.  A simplified subnormothermic machine perfusion system restores ischemically damaged liver grafts in a rat model of orthotopic liver transplantation.

Authors:  Tim A Berendsen; Bote G Bruinsma; Jungwoo Lee; Vincent D'Andrea; Qiang Liu; Maria-Louisa Izamis; Korkut Uygun; Martin L Yarmush
Journal:  Transplant Res       Date:  2012-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.